Product NDC: | 0025-0166 |
Proprietary Name: | Synarel |
Non Proprietary Name: | nafarelin acetate |
Active Ingredient(s): | 2 mg/mL & nbsp; nafarelin acetate |
Administration Route(s): | NASAL |
Dosage Form(s): | SPRAY, METERED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0025-0166 |
Labeler Name: | G.D. Searle LLC Division of Pfizer Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019886 |
Marketing Category: | NDA |
Start Marketing Date: | 19900213 |
Package NDC: | 0025-0166-08 |
Package Description: | 1 BOTTLE, SPRAY in 1 CARTON (0025-0166-08) > 8 mL in 1 BOTTLE, SPRAY |
NDC Code | 0025-0166-08 |
Proprietary Name | Synarel |
Package Description | 1 BOTTLE, SPRAY in 1 CARTON (0025-0166-08) > 8 mL in 1 BOTTLE, SPRAY |
Product NDC | 0025-0166 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | nafarelin acetate |
Dosage Form Name | SPRAY, METERED |
Route Name | NASAL |
Start Marketing Date | 19900213 |
Marketing Category Name | NDA |
Labeler Name | G.D. Searle LLC Division of Pfizer Inc |
Substance Name | NAFARELIN ACETATE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Gonadotropin Releasing Hormone Receptor Agonist [EPC],Gonadotropin Releasing Hormone Receptor Agonists [MoA] |